
Xuefeng Yu, CanSino Biologics CEO (Imaginechina via AP Images)
Covid-19 roundup: CanSino’s inhaled vaccine gets thumbs-up from Chinese regulators; Sinovac gets go-ahead for booster trial in Chile
While the world has been focused on injectable booster shots to address the Omicron variant, one company focused on a different approach has seen its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.